Author: Cho, Sung-Yeon; Lee, Hyeon-Jeong; Lee, Dong-Gun
Title: Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea Document date: 2018_2_27
ID: t9tysvr8_2
Snippet: Until the 1970s, HSCTs were simply classified as au- tologous or allogeneic according to their donor status, and survival rates were very low. Since the introduction of the human leukocyte antigen (HLA) concept, the incidence of graft failure and/or graft-versus-host disease (GVHD) has decreased. In recent years, allogeneic HSCT has involved various sources of hematopoietic stem cells (bone marrow, peripheral stem cell, cord blood, and mesenchyma.....
Document: Until the 1970s, HSCTs were simply classified as au- tologous or allogeneic according to their donor status, and survival rates were very low. Since the introduction of the human leukocyte antigen (HLA) concept, the incidence of graft failure and/or graft-versus-host disease (GVHD) has decreased. In recent years, allogeneic HSCT has involved various sources of hematopoietic stem cells (bone marrow, peripheral stem cell, cord blood, and mesenchymal cells), donors (sibling, unrelated, haploidentical), and conditioning regimens (standard [myeloablative], reduced intensity). Supportive therapies such as transfusion, colony stimulating factors, and antimicrobial agents have also been developed. Although various early diagnosis and therapeutic techniques have been developed to improve transplant performance, infectious diseases still affect the prognosis of HSCT recipients [2] [3] [4] .
Search related documents:
Co phrase search for related documents- cord blood and mesenchymal cell: 1, 2, 3, 4, 5, 6, 7, 8
- cord blood and mesenchymal cell cord blood: 1, 2
- cord blood and peripheral stem cell: 1, 2, 3, 4, 5, 6, 7, 8
- cord blood and reduced intensity: 1, 2, 3, 4, 5, 6
- donor status and infectious disease: 1
- early diagnosis and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- early diagnosis and mesenchymal cell: 1
- early diagnosis and recent year: 1, 2, 3, 4, 5, 6
- graft failure and peripheral stem cell: 1, 2, 3, 4, 5
- graft failure and reduced intensity: 1, 2, 3, 4, 5, 6
- graft failure incidence and peripheral stem cell: 1
- GVHD host versus graft disease and infectious disease: 1, 2, 3, 4, 5
- GVHD host versus graft disease and mesenchymal cell: 1, 2, 3, 4, 5
- GVHD host versus graft disease and peripheral stem cell: 1, 2, 3, 4, 5, 6
- GVHD host versus graft disease and reduced intensity: 1, 2, 3, 4, 5, 6, 7, 8, 9
- hematopoietic stem cell and infectious disease: 1, 2, 3, 4
- hematopoietic stem cell and mesenchymal cell: 1, 2, 3, 4
- hematopoietic stem cell and peripheral stem cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- hematopoietic stem cell and reduced intensity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Co phrase search for related documents, hyperlinks ordered by date